Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big pharmaceutical partners, which are keen to lower expenses and boost efficiency of the costly drug development process.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully have some AI-designed drugs in clinical trials by the end of the year,

The Chinese startup DeepSeek released an AI reasoning model that appears to rival the abilities of a frontier model from OpenAI, the maker of ChatGPT.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical tasks like trip planning. Here's how it works.

What Could Possibly Go Right with Our AI Future," the LinkedIn co-founder makes the case that AI can extend human

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have

Tech investor and LinkedIn co-founder Reid Hoffman is teaming up with cancer researcher Siddhartha Mukherjee on an artificial intelligence drug discovery startup that is launching with $24.6 million of initial funding.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, intriguing people and fast cars are all AI.

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Major tech company's new AI algorithm can predict the weather with incredible accuracy — here's why it won't replace forecasters first appeared on The Cool Down.